MedTech Europe has established several specific country focus groups that follow market access, regulatory convergence, ethics and compliance. These groups can address laws that affect the industry, such as restrictions on medical devices imports, discriminatory procurement rules, and price controls. Country focus groups are currently established for Russia, China, India, Brazil and Middle-East/Africa.
Country Focus
Medical technology companies operate in diverse global markets. Insights on regulatory, ethical, procurement environment are essential to expanding to new markets.
-
Jesús Rueda Rodríguez
Director General
[email protected]Jesús Rueda Rodríguez
Director General
Jesús heads the International Affairs team. He is involved in the work at the international level acting as representative to WHO, ISO and as liaison to other associations on all regulatory matters.
Directly involved in the discussions on the revision and recast of the IVD Directive, he previously lead the regulatory debates that affect IVDs at EU level until 2016.
A Spanish national with a biochemistry background, he is also fluent in English and French.
-
Diana Kanecka (On Maternity Leave)
Senior Manager International Affairs
[email protected]Diana Kanecka (On Maternity Leave)
Senior Manager International Affairs
Diana Kanecka works at the International Affairs team at MedTech Europe where she is responsible for coordinating several projects aimed at enabling trade and overcoming barriers to the market for medical technologies. Previously, Diana worked within MedTech Europe on several regulatory topics following IVD, medical device and chemicals legislation. Diana is a Polish national and she holds a Master’s degree in European Union law from the King’s College of London and a Master’s degree in interdisciplinary European studies/European single market from the College of Europe. Diana has a strong interest in trade policy and regulatory topics. She was also an active member of the European Health Parliament initiative where she worked with the committee on the ‘economic dimension of healthcare’ on development of recommendations on the future of healthcare systems.
